These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 9238409)

  • 1. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus.
    Okin PM; Roman MJ; Devereux RB; Kligfield P
    J Electrocardiol; 1996; 29 Suppl():256-61. PubMed ID: 9238409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity.
    Okin PM; Roman MJ; Devereux RB; Kligfield P
    J Am Coll Cardiol; 1996 Jan; 27(1):124-31. PubMed ID: 8522685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy.
    Oikonomou E; Theofilis P; Mpahara A; Lazaros G; Niarchou P; Vogiatzi G; Tsalamandris S; Fountoulakis P; Christoforatou E; Mystakidou V; Anastasiou M; Goliopoulou A; Tousoulis D
    Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12728. PubMed ID: 31724804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
    J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging.
    Nomsawadi V; Krittayaphong R
    Ann Noninvasive Electrocardiol; 2019 Jul; 24(4):e12635. PubMed ID: 30719815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between echocardiographic left ventricular mass index and electrocardiographic variables used in left ventricular hypertrophy criteria in Chinese hypertensive patients.
    Xie L; Wang Z
    Hellenic J Cardiol; 2010; 51(5):391-401. PubMed ID: 20876051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients.
    Snelder SM; van de Poll SWE; de Groot-de Laat LE; Kardys I; Zijlstra F; van Dalen BM
    Clin Cardiol; 2020 May; 43(5):483-490. PubMed ID: 31990994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy.
    Okin PM; Roman MJ; Devereux RB; Pickering TG; Borer JS; Kligfield P
    Hypertension; 1998 Apr; 31(4):937-42. PubMed ID: 9535418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
    Ishikawa J; Yamanaka Y; Watanabe S; Toba A; Harada K
    Hypertens Res; 2019 Apr; 42(4):541-548. PubMed ID: 30542082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and ECG left ventricular hypertrophy.
    Muiesan ML; Salvetti M; Di Castelnuovo A; Paini A; Assanelli D; Costanzo S; Badilini F; Vaglio M; Donati MB; Agabiti Rosei E; de Gaetano G; Iacoviello L;
    J Hypertens; 2017 Jan; 35(1):162-169. PubMed ID: 27662187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.
    Mahn JJ; Dubey E; Brody A; Welch R; Zalenski R; Flack JM; Ference B; Levy PD
    Acad Emerg Med; 2014 Sep; 21(9):996-1002. PubMed ID: 25269580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
    Okin PM; Wright JT; Nieminen MS; Jern S; Taylor AL; Phillips R; Papademetriou V; Clark LT; Ofili EO; Randall OS; Oikarinen L; Viitasalo M; Toivonen L; Julius S; Dahlöf B; Devereux RB
    Am J Hypertens; 2002 Aug; 15(8):663-71. PubMed ID: 12160187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of obesity on the diagnostic value of electrocardiographic criteria for detecting left ventricular hypertrophy.
    Abergel E; Tase M; Menard J; Chatellier G
    Am J Cardiol; 1996 Apr; 77(9):739-44. PubMed ID: 8651126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjustment of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy. The effects of hypertension and obesity.
    Norman JE; Levy D
    J Electrocardiol; 1996; 29 Suppl():241-7. PubMed ID: 9238407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M; Korzeniowska B; Tendera M
    Int J Cardiol; 2006 Jan; 106(3):382-9. PubMed ID: 15996771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
    Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants and improvement of electrocardiographic diagnosis of left ventricular hypertrophy in a black African population.
    Jingi AM; Noubiap JJ; Kamdem P; Kingue S
    PLoS One; 2014; 9(5):e96783. PubMed ID: 24810594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.